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Background: Meniscectomy is a risk factor for knee osteoarthritis, with increased medial joint loading a likely
contributor to the development and progression of knee osteoarthritis in this group. Therefore, post-surgical
rehabilitation or interventions that reduce medial knee joint loading have the potential to reduce the risk of
developing or progressing osteoarthritis. The primary purpose of this randomised, assessor-blind controlled trial is
to determine the effects of a home-based, physiotherapist-supervised neuromuscular exercise program on medial
knee joint load during functional tasks in people who have recently undergone a partial medial meniscectomy.
Methods/design: 62 people aged 30–50 years who have undergone an arthroscopic partial medial meniscectomy
within the previous 3 to 12 months will be recruited and randomly assigned to a neuromuscular exercise or control
group using concealed allocation. The neuromuscular exercise group will attend 8 supervised exercise sessions with
a physiotherapist and will perform 6 exercises at home, at least 3 times per week for 12 weeks. The control group
will not receive the neuromuscular training program. Blinded assessment will be performed at baseline and
immediately following the 12-week intervention. The primary outcomes are change in the peak external knee
adduction moment measured by 3-dimensional analysis during normal paced walking and one-leg rise. Secondary
outcomes include the change in peak external knee adduction moment during fast pace walking and one-leg hop
and change in the knee adduction moment impulse during walking, one-leg rise and one-leg hop, knee and hip
muscle strength, electromyographic muscle activation patterns, objective measures of physical function, as well as
self-reported measures of physical function and symptoms and additional biomechanical parameters.
Discussion: The findings from this trial will provide evidence regarding the effect of a home-based,
physiotherapist-supervised neuromuscular exercise program on medial knee joint load during various tasks in
people with a partial medial meniscectomy. If shown to reduce the knee adduction moment, neuromuscular
exercise has the potential to prevent the onset of osteoarthritis or slow its progression in those with early disease.
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Osteoarthritis (OA) is a common musculoskeletal dis-
ease that is considered by the World Health Organisa-
tion as one of the ten leading causes of disease burden
in high-income countries [1]. The knee is the most com-
monly affected lower limb joint [2]. Osteoarthritis is
associated with pain, reduced physical function and high
economic costs [3-5]. Given there is no cure for OA, it
is widely recognised that OA prevention, particularly tar-
geting groups at greater risk of developing the condition,
is an important research priority to reduce the personal
and societal disease burden [6]. Individuals who have
undergone an arthroscopic partial meniscectomy (APM),
a common surgical procedure for meniscal injury par-
ticularly involving the medial meniscus [7], constitute
one such group at risk of tibiofemoral knee OA [8].
Meniscal tears can be categorised as traumatic or degen-
erative tears. Traumatic tears are typically longitudinal
tears and result from an acute sports-related injury in
young active individuals [9,10]. Alternatively, degenera-
tive tears are generally observed as horizontal-cleavage
lesions or flap tears [11] in middle-aged and older popu-
lations [10]. These degenerative tears are suggested as
the first sign of knee OA [12]. In fact, it is estimated that
50% of individuals have radiographic signs of knee OA
within 10–15 years following meniscectomy [12-14].
Moreover, accumulating magnetic resonance imaging
(MRI) data suggest that structural changes begin soon
after APM. Studies have observed an increase in cartil-
age loss over 2 years following APM [15], and a greater
prevalence of cartilage defects between 3 months and 4
years post-APM [16] as compared to healthy controls.
Furthermore, medial femoral cartilage integrity as mea-
sured by glycosaminoglycan (GAG) content was
impaired 4 years following medial APM when compared
to the reference lateral femoral condyle cartilage [17].
These findings highlight the urgent need to develop and
evaluate rehabilitative interventions that may reduce the
likelihood of OA development in this patient group.
The onset of knee OA following APM may be partly
related to a higher distribution of medial knee joint load.
The external knee adduction moment (KAM), is a
widely used biomechanical marker of medial knee load
distribution measured via three-dimensional gait ana-
lysis. Indeed a large cross-sectional study reported that
individuals 3-months post-APM surgery had ~18%
higher peak KAM bilaterally as compared to healthy
controls during walking [18]. This highlights the greater
medial distribution of knee joint load during walking in
patients’ post-APM. The finding of higher medial joint
load distribution post-APM is relevant to the pathogen-
esis of knee OA. The peak KAM is generally higher in
those with established structural medial knee OA than
in healthy controls [19-22] and also correlates with kneeOA severity as measured on radiographs [21,23]. Fur-
thermore, longitudinal studies have associated the peak
KAM with the development of chronic knee pain in
older people [24] as well as an increased risk of radio-
graphic OA progression in those with established disease
[25]. A greater KAM impulse, which takes into account
the average magnitude and duration of medial loading
throughout stance and may be a more sensitive marker
of medial joint dynamic loading than peak KAM [26],
has also been related to cartilage degradation in people
following APM [27] and in those with knee OA [28].
Thus, it is apparent that medial knee joint loading (as in-
ferred by KAM parameters) is associated with the patho-
genesis of knee OA and if reduced, could potentially
prevent or delay OA-initiation and progression in people
following APM of the medial meniscus.
Exercise may be an effective strategy to reduce the
greater medial knee joint load distribution observed
post-APM. Exercise is recommended as part of rehabili-
tation post-meniscal surgery [29] and is also an attract-
ive rehabilitation option considering that it is relatively
safe, is a patient-driven strategy that can facilitate long-
term self-management, is inexpensive and is clinically
advocated in knee OA management [30,31]. There is
limited evidence as to the effects of different exercise
types on knee joint loading. Studies have examined the
effects of knee and hip muscle strengthening [32-34] on
medial knee joint loading in older patients with estab-
lished symptomatic and radiographic knee OA. Despite
improving OA-associated symptoms, no change in med-
ial knee joint loading was found during walking with the
tested strengthening programs [33,34]. However, some
pilot evidence suggests that neuromuscular exercise may
reduce loading across the knee joint in people with and
without knee OA during more functionally challenging
tasks than walking [35,36].
Neuromuscular training is a broad term used to in-
corporate many components of exercise training includ-
ing: balance, perturbation, agility, plyometrics, strength
and endurance [37,38]. Furthermore, neuromuscular
training programs are designed with various aims: to
prevent sports injuries in young athletes [39], to rehabili-
tate individuals post-sport related injuries [40] and more
recently to prevent OA progression [37]. Therefore it is
important to acknowledge that a vast array of exercises
and intensities are considered neuromuscular in nature.
However, regardless of the target population or aim of
the training program, a common feature of neuromuscu-
lar training is the use of functional weight-bearing exer-
cise positions. Physiologically, neuromuscular training
aims to enhance the unconscious motor response by
calling upon both afferent signal and central mechan-
isms responsible for dynamic control [41]. A randomised
controlled trial (RCT) reported that following a 4-month
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improved one-leg hop for distance and improved self-
reported outcomes [17,42]. Importantly, this RCT also
found improved cartilage quality as indicated by the
GAG content on MRI following the neuromuscular ex-
ercise program [43]. Neuromuscular training has been
found to reduce external abduction knee loads in young
healthy females while landing from a jump [35] adding
support to the premise that neuromuscular exercise can
alter frontal plane moments. Of particular relevance to
the current study is evidence that peak KAM can be
reduced with neuromuscular exercise in middle-aged
individuals with moderate levels of knee OA [36]. This
uncontrolled pilot study included 13 individuals and
found a 14% reduction in peak KAM during a one-leg
rise task with no difference in peak KAM during walking
following the 8-week training period. Despite the differ-
ence in the purposes of the neuromuscular exercise
training programs [35,36], these findings from healthy
and OA cohorts suggest that neuromuscular training has
potential to reduce frontal plane knee moments. Fur-
thermore, these studies suggest that potential alterations
in knee joint load distribution appear to be detected dur-
ing more challenging motor tasks following neuromus-
cular training. This hypothesis is further supported by
recent cross-sectional evidence in APM individuals de-
scribing altered neuromuscular function during a forward
lunge [44] that were not detected during stair descent
when comparing the operated and non-operated legs [45].
Given that neuromuscular training has the potential to
alter knee joint load, we hypothesise that neuromuscular
training may be an effective load-modifying intervention
to rehabilitate individuals post-APM, a patient group at
risk of developing knee OA. However to date, this has
not been evaluated. The primary objective of this study
(‘SCOPEX’) is to determine whether a neuromuscular
exercise program (‘ALIGN’) reduces medial knee joint
loading in people with a recent medial APM, as mea-
sured by the peak external KAM during normal pace
walking and one-leg rise. The secondary objectives are
to evaluate the effect of the ALIGN program post-
medial APM on: i) the peak external KAM during fast
pace walking and one-leg hop for distance; ii) the exter-
nal KAM impulse during: walking (normal pace and fast
pace), one-leg rise and one-leg hop for distance; iii) knee
and hip muscle strength; iv) electromyographic muscle
activation patterns; v) functional physical performance
and vi) patient-reported outcomes knee pain, other
symptoms, activities of daily living, sport and recreation
and knee-related quality of life.
Primary hypothesis
The 12-week neuromuscular exercise program will re-
duce medial knee joint loading, as characterised by thepeak external KAM during normal pace walking and
one-leg rise, when compared to a control group not re-
ceiving the neuromuscular exercise program.
Secondary hypotheses
The 12-week neuromuscular exercise program will: i) re-
duce the peak external KAM during fast-pace walking
and one-leg hop for distance; ii) reduce the external
KAM impulse during walking (normal and fast pace),
one-leg rise and one-leg hop for distance; iii) improve
knee and hip muscle strength; iv) alter electromyo-
graphic muscle activation patterns; v) improve functional
physical performance; vi) improve self-reported out-
comes (knee pain, other symptoms, activities of daily
living, function, sport and recreation function and knee-
related quality of life) when compared to a control
group.
Methods
Trial design
This will be an assessor-blinded, randomised controlled
trial of a 12-week physiotherapist-supervised and home-
based neuromuscular exercise intervention. Assessment
will be performed at baseline and immediately following
the intervention (12 weeks). The protocol conforms to
CONSORT guidelines for non-pharmacological studies
[46] (Figure 1) and has been registered with the Austra-
lia and New Zealand Clinical Trials Registry prior to
study commencement.
Participants
Sixty-two participants with a recent isolated medial
APM will be recruited from metropolitan Melbourne,
Australia. The primary recruitment strategy will be via
screening of surgical records of several Melbourne-based
orthopaedic surgeons. Additionally, we will recruit indi-
viduals by advertising through University staff newslet-
ters and Facebook. To be eligible, participants must be
aged between 30–50 years and have undergone an iso-
lated medial APM in the past 3–12 months.
The exclusion criteria are:
i) an average overall pain severity ≥3 out of 10 on an
11 point numerical rating scale in the past week
ii) signs of moderate to severe radiographic knee OA
(Kellgren-Lawrence grade >2) [47]
iii) full tears of the anterior or posterior cruciate knee
ligaments
iv) anterior or posterior ligament reconstructions
v) spinal or lower extremity pain (other than the
affected knee) that limits everyday activities or
required treatment in the past month
vi) high levels of physical activity defined as
participation in an organised team or individual
Assessed for eligibility 
by telephone
Baseline Assessment
Randomisation
Experimental group:
Neuromuscular training
Control group: 
No training
Physiotherapists (n = 12) Private physiotherapy clinics
8 x individual training sessions plus home program 
(exercise 3 times per week) over 12 weeks
Week 13:  Assessment: Immediately post neuromuscular intervention
Intention-to-treat-analysis
Ineligible:
Fail inclusion criteria
Meet exclusion criteria
Ineligible:
Fail inclusion criteria
Meet exclusion criteria
Xray screening
Figure 1 Trial Protocol.
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requires some form of systematic training [48]
vii) history of lower limb surgery (other than knee
arthroscopy)
viii) other form of arthritis, diabetes, cardiac circulatory
conditions that limit everyday activities (as
determined by the Self-administered Co-morbidity
Questionnaire)[49]
ix) neurological condition such as Parkinson’s disease,
multiple sclerosis or stroke
x) any condition precluding safe participation in
exercise(xi) unable to complete the study protocol
(xii) inadequate written or spoken English
Procedure
Individuals who meet the inclusion criteria will be sent
information in the mail. Approximately two weeks later
these individuals will be contacted by telephone and
invited to undergo further screening for exclusion cri-
teria. Screening records will be maintained to detail the
criteria eliminating individuals found to be ineligible.
Following further screening for exclusion criteria via
telephone, people who are potentially eligible will
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their partially meniscectomised knee at one of three trial
radiology centres (unless they can provide their own
radiographs taken within the past 12 months). The x-
rays will be graded by one of two experienced clinicians.
Eligible participants will attend the Centre for Health
Exercise and Sports Medicine (CHESM) at The Univer-
sity of Melbourne for baseline and follow-up testing.
Following baseline testing, participants will be rando-
mised into one of two groups: i) neuromuscular exercise
training; or (ii) no neuromuscular exercise training. The
12-week neuromuscular exercise training intervention
will include 8 individual physiotherapist visits: twice in
the first week, one in each of the second and third weeks
and fortnightly thereafter. Participants in this group will
also perform a home-based exercise program throughout
the 12-week intervention. All participants will provide
written informed consent.Blinding
Baseline and follow-up assessments will be performed by
the same outcome assessor who will remain blinded to
group allocation and who will not be involved in provid-
ing the neuromuscular exercise program. Furthermore,
the outcome assessor will not visit any of the physiother-
apist centres. Participants will be instructed not to dis-
close details about their group allocation to the blinded
assessor. By virtue of the design, it is not possible to
blind the participants or the physiotherapists.Randomisation and allocation concealment
A researcher with no other involvement in the study will
prepare the randomisation schedule a priori using a
computer generated random numbers table. Randomisa-
tion will be conducted by random permuted blocks of
size 6 to 8 and stratified by gender. To conceal random-
isation, the same independent researcher will prepare
consecutively numbered, sealed opaque envelopes. The
envelopes will be kept in a locked location and only ac-
cessible to the independent researcher responsible for
randomising participants following baseline testing. An-
other independent researcher will then schedule the first
two physiotherapist appointments for those in the
neuromuscular exercise group.Intervention
Participants will be asked to refrain from seeking other
forms of treatment during the trial. Additionally, partici-
pants from both groups will be asked to refrain from
performing additional physical activity to what they cur-
rently perform. Analgesia will be permitted as required.Neuromuscular exercise group
Similar to previous neuromuscular exercise programs
described for knee OA patients [37,38], our neuromus-
cular exercise program, ALIGN, is based on biomechan-
ical and neuromuscular principles that aim to improve
sensorimotor function. Considering that the context of
the current study is OA prevention and delay of progres-
sion, participants will be instructed to focus neutral
alignment of the hip, knee and foot during weight bear-
ing positions. Furthermore, participants will also be
encouraged to focus on the performance quality of each
exercise. The neuromuscular exercise intervention,
ALIGN will target muscles of both lower limbs. The
exercises were selected based on previous research dem-
onstrating these exercises or similar variations to have
reduced medial knee joint load, improved cartilage qual-
ity and physical function in people at risk of developing
or progressing established knee OA [36,42,43].
Study physiotherapists
Twelve physiotherapists in private practices at multiple
locations throughout metropolitan Melbourne, Australia
will deliver the neuromuscular exercise program titled
“ALIGN”. The physiotherapists have an average of 15
years (range 3–36 years) of clinical experience since
qualification and 11 years (range 0–27) of post-graduate
clinical musculoskeletal experience. Three (25%) have a
postgraduate Masters qualification in sports or manipu-
lative/musculoskeletal therapy. The physiotherapists will
attend a 3-hour training session addressing the delivery
of the neuromuscular exercise program and receive a
detailed treatment manual. This large number of study
physiotherapists is necessary for feasibility and to im-
prove the generalisability of study findings. Physiothera-
pists will be supplied with equipment for their clinics to
demonstrate the exercises to participants. Participants
will choose a project physiotherapist to attend based on
their geographical location and time availability. Train-
ing will commence within one week of baseline
assessment.
First physiotherapist visit
The initial visit with the physiotherapist will last 45 min-
utes, during which participants will be educated about
the goals and benefits of the neuromuscular exercise
program. Potential barriers to exercise will also be
addressed. Individuals with knee OA have expressed that
pain or the fear of pain prevents exercise participation
[50]. Therefore, participants will use a pain monitoring
scale to guide their home exercises, where zero repre-
sents “no pain” and ten represents “worst possible pain”.
On this scale, exercising with a pain score up to two is
considered ‘safe’, exercising with pain up to five is con-
sidered ‘acceptable’ and exercise when pain scores are
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the minimal levels of pain in this cohort, we do not an-
ticipate that pain will be an issue. Nonetheless, it is
thought that monitoring knee pain before and after each
exercise session will give participants confidence to exer-
cise. Another commonly expressed barrier to exercise is
lack of time [52]. During the first session, physiothera-
pists will encourage participants to consider how they
can best fit the neuromuscular exercise sessions into
their weekly schedule. Following the initial education
and discussion of exercise barriers, participants will be
taught their individualised training program by the
physiotherapist. The 6 core exercises in the ‘ALIGN’ pro-
gram are described in Table 1. Physiotherapists will de-
termine the appropriate starting level of each exercise
for individual participants based on the quality of per-
formance by the participant and the verbalised degree of
difficulty from participants.
Home training sessions
Participants will be instructed to perform their indivi-
dualised neuromuscular exercises at home three times
per week in addition to exercises performed during
scheduled supervised physiotherapy visits. Each session
will last approximately 30–35 minutes, accumulating to
a total of >90 mins of exercise per week. Despite there
being no specific guidelines for neuromuscular training,
based on the authors’ experience and the American Col-
lege of Sports Medicine recommendations for neuromo-
tor exercise, (2–3 days per week; 20–30 minutes each
day) [53], it was considered that >90 minutes per week
would be adequate for physiological adaptations.
Follow-up physiotherapist sessions
During the subsequent seven physiotherapist sessions
each lasting 30 minutes, physiotherapists will assess ad-
herence to the home exercise program by reviewing the
participants’ weekly logbook and inquiring about any ad-
verse events experienced. Physiotherapists will thenTable 1 Neuromuscular exercise program; ALIGN
Exercise Primary Muscles Targeted Description of starting leve
Abdominal
crunches
Abdominal muscles Performed in supine with kne
bridge Hamstrings, gluteals, hip
adductors
Performed in supine with kne
with a towel between knees
Lunge Gluteals, knee extensors and
flexors
Standing upright, participants
Incomplete
circle
Hip abductors Performed in a unipedal stan
Get tapping Knee extensors and hip
abductors
Performed in a unipedal stan
kNee bends Knee extensors, gluteals and
hip abductors
Performed in a bipedal stance
bottom nearly touches the chassess exercise technique and increase the exercise
intensity (in terms of the level) as necessary. Exercise
progression will be based on the physiotherapists’ assess-
ment of the quality of the exercise performance and on
the participant’s reported pain response and degree of
difficulty experienced. Varying surfaces and weight will
be used to increase the exercise difficulty. The 6 core
exercises and respective levels of difficulty are detailed
in an Additional File. During the period between physio-
therapy visits, participants are also encouraged to pro-
gress by increasing the volume of the repetitions and
sets. Participants will start performing 2 sets of 12
repetitions. Participants can progress their training by
opting to increase the volume to 2 sets of 15 repeti-
tions; 3 sets of 12 repetitions and 3 sets of 15 repeti-
tions respectively. However, the level of difficulty is, as
previously described, increased by the physiotherapist.
Physiotherapists will maintain standardised treatment
notes.Control group
Participants in the control group will not receive any
interventions during the 12-week study period.Outcome measures
Baseline descriptive data including age, gender, date of
surgery, surgical procedure performed, and the knee
undergoing surgery will be obtained by questionnaire
and from surgical records. Radiographic disease severity
will be assessed from the screening x-ray using the
Kellgren and Lawrence grading system [47]. Height and
body mass will be measured. For a summary of all mea-
sures collected in the study see Table 2.External knee adduction moment
Three-dimensional movement analysis will be used to
assess participant’s movement as they perform threel
es flexed on exercise ball, participants perform abdominal crunches
es flexed on the exercise ball, participants rise up and hold the position
lunge forward and return to starting position
ce while the opposite limb rotates in a semi-circular motion
ce on a stepper, as the opposite leg taps the ground behind the step
in front of a chair with feet hip width apart, knees are bend so the
air or heels remain in full contact with the floor
Table 2 Outcome measures summary
Primary outcome measures
Peak external knee adduction moment during stance a) Walking (normal pace)
b) One-leg rise
Secondary outcome measures
Peak external knee adduction moment during stance a) Walking (fast pace)
b) One-leg hop for distance
External knee adduction moment impulse during stance a) Walking (normal pace and fast pace)
b) One-leg rise
c) One-leg hop for distance
Knee and hip muscle strength Isometric and isokinetic knee extensors and flexors (isokinetic
dynamometer)
Isometric hip abductors and hip adductors (instrumented manual muscle
tester)
Muscle activity patterns and co-contractions Surface electromyography
Objective functional performance a) One-leg rise
b) Knee bends
c) One-leg hop for distance
Pain, other symptoms, function in ADL and Sport and Recreation, quality
of life
Knee injury and osteoarthritis outcome score
Other measures
Peak external knee flexion moment 3-dimensional movement analysis
Dynamic tibial alignment, lateral trunk lean angle, internal foot rotation
angle
3-dimensional movement analysis
Static alignment Inclinometer
Disease severity X-ray (baseline)
Physical activity levels Lower Extremity Activity Scale
Adverse events Participant log-book (follow-up)
Adherence to exercise program Participant log-book (follow-up)
Treatment session attendance Therapist treatment records (intervention group only) (follow-up)
All measures are obtained at baseline and 13 weeks, unless otherwise indicated.
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Volley, Pacific Brands, Australia): i) walking (normal and
fast pace), ii) one-leg rise and iii) one-leg hop for dis-
tance. Kinematic and kinetic data will be recorded using
a 12-camera motion analysis system (Vicon MX, Oxford,
UK) and three force plates (AMTI, MA, USA). Partici-
pants will be assessed while walking at two speeds: a
normal pace walk described to participants as ‘the pace
you would walk normally’ and a fast pace walk described
as ‘the pace you would walk in a hurry’. Walking speed
will be monitored, and six successful trials for normal
and fast pace (defined as a complete foot strike on a sin-
gle force plate) will be collected for each leg. At follow-
up, if the average walking speed of the six trials for either
normal pace or fast pace walking is outside a ±5% range
from baseline walking speed, participants will be asked to
adjust their walking speed accordingly. This is to ensure
that six trials are collected within 5% of baseline walking
speed.For the one-leg rise task, participants will be seated in
a standardised position with a chair height of 48cm, seat
depth of 75% thigh length and 100° knee flexion. Partici-
pants will be instructed to flex the non-test knee holding
the leg off the ground throughout the task, and rise from
the seat using the test leg (leg being assessed) until
standing upright, and then return to the seated position.
If participants cannot rise from the seat, the chair height
will be increased in increments of 2.5cm until the task
can be achieved. Following two practice trials, three
trials will be recorded and averaged for each leg. For the
one-leg hop for distance task, participants will be
instructed to stand on one foot with their arms across
their chest and instructed to jump as far forward as pos-
sible and land steadily, without over-balancing on the
same foot. Following, two practice trials at submaximal
effort, three maximum trials where a complete foot
lands on a single force plate will be averaged and col-
lected for each leg. In an effort to minimise fatigue, three
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demanding tasks (one-leg rise and one-leg hop). Reflect-
ive markers will be placed on the participant according
to the University of Western Australia (UWA) marker
set [54]. Data from the reflective markers (sample rate
120Hz) and ground reaction forces (sample rate
1200Hz) will be used to calculate external joint
moments via inverse dynamics (Besier et al., 2003). The
primary variables of interest are the peak external KAM
(Nm/(BWxHT) %) and KAM impulse (Nm.s/(BWxHT)
%), both normalised for body weight times height. The
test-retest reliability of the UWA model for the external
frontal plane moment curve during walking is 0.75 (co-
efficient of multiple determination, r2) [55]. Additional
outcome measures that can influence the KAM during
the stance phase will also be assessed, including frontal
plane alignment of the tibia, peak external knee flexion
moment, trunk lean in the frontal plane and internal
foot rotation.
Muscle strength
Isometric and isokinetic knee muscle strength and
isometric hip abductor and adductor strength will be
assessed on the previously operated leg. Maximal iso-
metric quadriceps and hamstring strength will be mea-
sured at 60° knee flexion using a dynamometer (Humac
NORM, CSMI, Massachusetts, USA). Participants will
be secured in a standardised seated position. For knee
strength assessment, participants will perform two sub-
maximal efforts, followed by 3 maximal isometric con-
tractions for 5 seconds each, and separated by 40 seconds
rest. The maximum of 3 trials will be used for analysis.
Following sub-maximal isokinetic practice efforts, max-
imal concentric isokinetic quadriceps and hamstring
strength at 60°/sec will be measured with the participant
performing 5 maximal efforts. The test-re test reliability
for isometric knee strength in our laboratory for knee
OA individuals is ICC 0.93.
Maximal isometric hip abductor and adductor torque
will be measured using a hand-held dynamometer
(Lafayette MMT 01163, Lafayette Instruments, IN,
USA). For these hip strength assessments, participants
will be positioned in supine with the study limb in slight
abduction with no hip or knee flexion and with the pel-
vis and contralateral limb stabilised (Pua et al., 2008).
The dynamometer will be placed over the lateral and
medial femoral condyles for the hip abduction and ad-
duction efforts, respectively. After a single sub-maximal
attempt participants, will be instructed to perform two
maximal trials each of 3 seconds duration, separated by
40 seconds of rest. For the hip strength assessments, the
mean of two maximal trials will be used in the analysis.
The reliability for hip abductor strength in our labora-
tory for hip OA individuals is excellent (ICC 0.84; 95%CI 0.55-0.94) [56]. For hip adductor strength, reliability
in healthy individuals is ICC 0.78 (95% CI; 0.30-0.95) al-
beit, a slight variation on the method used in the current
study [57]. All participants will receive strong standar-
dised verbal encouragement to give their best effort dur-
ing maximal trials. All strength data will be reported as
torque normalised to body mass (Nm/kg).Muscle co-contraction and activation patterns
Muscle activity will be recorded during walking, one-leg
rise and hop for distance trials using surface electro-
myography (EMG) sampled synchronously with kine-
matic data via a telemetered Noraxon Telemyo 900
system (Noraxon, AZ, USA). Surface electrodes will be
placed unilaterally on the gluteus medius, quadriceps
(vastus lateralis and medialis, rectus femoris), hamstrings
(biceps femoris and semimembranosus) and medial and
lateral gastrocnemius of the APM leg. EMG recordings
during maximal isometric knee flexion, knee extension,
hip abduction and plantar flexion will be used to nor-
malise EMG data during walking, one-leg rise and hop
for distance tasks. Total activation and relative activation
of individual and grouped muscles will be investigated.Objective measures of function
Functional tests will be performed for each leg and will
include the i) 30 second one-leg rise test; ii) 30-second
knee bend test, and iii) one-leg hop for distance test. For
the one-leg rise test, participants will sit in a standar-
dised seated position (as described above). Participants
will flex the non-test leg and rise from the seat using the
test leg until standing upright and return to the seated
position as quickly as possible. The number of suc-
cessful, controlled one-leg rises from the chair during
30-seconds will be counted. The 30-second knee bend
test assesses endurance of the hip and knee extensors.
Participants will begin the test in a standardised position
in single-leg standing, with the long axis of the foot
aligned to a vertical line with toes placed perpendicularly.
Participants will be instructed to bend the knee without
bending at the hip, until the toes can no longer be seen
and return to an upright position as quickly as possible
[58]. The maximum number of complete repetitions
performed in 30 seconds will be recorded. The one-leg
hop test gives an indication of how much confidence
the participant has in their knee [59] and will be admi-
nistered as above. The distance will be measured from
the toe of the starting position to the heel of the landing
position. The farthest distance over three maximal
attempts will be recorded. The 30-second knee bend test
has been found to be reliable in meniscectomy patients
(ICC 0.92 CI 95% 0.86-0.96) while variations of the one-
leg rise test (ICC 0.84 CI 95% 0.69-0.92) and one-hop rise
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Self-reported measures
Self-reported knee pain, other symptoms, ADL function,
sport and recreation function and knee-related quality of
life will be measured with the Knee Injury Osteoarthritis
Outcome Score (KOOS). The KOOS consists of 42
items where each item has 5 possible answers (0–4),
normalised to a score of 100, where lower score indicate
worse symptoms. It has been shown to be valid and reli-
able in meniscectomised patients [60,61]. At the follow-
up assessment, participants will rate their pain severity
out of 10 on an 11-point numerical rating scale and their
perceived change in physical function over the 12-week
period (compared to baseline) on a seven-point ordinal
scale (1-much worse to 7-much better). Also, at follow-
up, participants will be questioned about their physio-
therapy treatment experience.
Other measures
A clinical measure of static knee alignment will be taken
using an inclinometer [62]. Participants will be asked to
stand comfortably, after which the tibial angle will be
measured with respect to the vertical. This measure has
been shown to be reliable (ICC = 0.94) and valid in rela-
tion to mechanical axis from full-length radiographs
(r = 0.80) [62]. Physical activity will be measured using
the Lower Extremity Activity Scale (LEAS), which will
provide a global indication of physical activity level. From
a series of options, participants select one option that
best describes their current physical activity level. The
LEAS is used in OA populations and has been found to
be reliable and valid [63]. Participant adherence to the
neuromuscular exercise program will be obtained by
recording the number of physiotherapy sessions attended
(out of a maximum number of eight). Participants will
maintain a logbook to record the number of home exer-
cises completed during the 12-week intervention period.
For the purpose of this study, we will consider good ad-
herence as: 1) at least 80% of physiotherapy sessions
attended (i.e. 6 physiotherapy visits) and 2) at least
80% of the training sessions completed (i.e. 29 training
sessions). Physiotherapists will also indicate their per-
ceived impression of the participant’s overall adherence
to the treatment on an 11-point numeric rating scale,
with 0 representing ‘not at all and 10 being ‘completely
as instructed’ [64].
Sample size
A sample size of 62 participants ensures adequate power
to detect significant changes in the external peak KAM
and KAM impulse after the 12-week study period. As
previously mentioned, a 14% reduction in peak KAMhas been reported during one-leg rise in an uncontrolled
study of people with knee OA following a neuromuscu-
lar exercise program [36]. Importantly, this reduction in
peak KAM may be clinically relevant as it potentially
corresponds to an approximate 2-fold reduction in risk
of OA disease progression [25]. Therefore, we anticipate
that a minimum 10% reduction in the peak KAM may
be feasible with our neuromuscular program and that
such a change may be potentially clinically meaningful.
We anticipate that the peak KAM will remain un-
changed in our control group participants. Based on our
previous peak KAM data from APM participants [65], a
10% reduction equates to an absolute change of approxi-
mately 0.2 Nm/(BWxHT)%. Cautious estimates of the
standard deviation of change scores are 0.3 Nm/
(BWxHT)%, based on knee OA data from our laboratory
investigating conservative treatments for knee OA [33].
Despite little being known about the clinically meaning-
ful difference for KAM impulse or the response to inter-
ventions, we speculate a 10% change in KAM impulse is
also feasible and potentially clinically meaningful follow-
ing a neuromuscular intervention. We also anticipate
that the KAM impulse will remain unchanged in our
control group participants. Based on our previous KAM
impulse data from APM participants [65], a 10% reduc-
tion equates to an absolute change of approximately
0.09 Nm.s/(BWxHT)%. Estimates of the standard devi-
ation of change scores are 0.10 Nm.s/(BWxHT)% based
on APM data from our laboratory where KAM impulse
did not change over 2 years [65]. Therefore, a total of 27
participants per group is required to detect our antici-
pated changes in peak KAM and KAM impulse (assum-
ing standard deviations as stated above) between the
groups with 80% power (2 sided test, alpha=0.05). To ac-
count for 15% attrition, we will recruit 31 participants
per group.
Data and statistical analysis
Data analysis will be performed in a blinded manner
and main comparative analyses between the two groups
will be performed using an intention-to-treat analysis
using all randomised participants. Multiple imputation
methods will be used to address missing follow-up data.
Participant characteristics and baseline data will be sum-
marised by descriptive statistics. T-tests or non-parametric
tests, as appropriate will be used to determine baseline
comparability between the two groups. One-way ANOVA
will be used to determine baseline comparability between
the two groups. A non-parametric test will be used to de-
termine baseline comparability for categorical data. For
each dependent variable, change scores for each partici-
pant will be calculated by subtracting the follow-up score
from the baseline score. Regression analyses adjusted for
baseline values of the dependent variable and sex (the
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between baseline and follow-up for each independent
variable. Standard diagnostic plots will check model
assumptions. All tests will be two-tailed and performed
at the 5% significance level.
Timeline
Ethics approval was granted in April 2012 from the
Human Research Ethics Committee of The University of
Melbourne (HREC: 11377168) and Radiation Safety
Human Services. The physiotherapists were recruited in
February and trained in May 2012. Participant recruit-
ment has commenced and it is expected that all partici-
pants will have completed the study by December 2013.
Discussion
There is a need to assess the effect of neuromuscular ex-
ercise on knee joint loading [66]. Neuromuscular exer-
cise is known to improve knee articular cartilage quality,
physical function and patient-reported outcomes [43,59]
demonstrating its potential benefits in rehabilitation
post-APM. However, the effects of neuromuscular exer-
cise on medial knee joint load in people at risk of devel-
oping knee OA or showing early signs of knee OA has
yet to be rigorously determined. The peak external
KAM was chosen as a primary outcome during normal
pace walking for two reasons. Firstly, this parameter has
been previously shown to be elevated post-APM relative
to healthy controls [18] and secondly because of its asso-
ciation with medial compartment knee joint load and
knee OA progression [20,25]. The peak external KAM
during a one-leg rise is also included as a primary out-
come considering it is a challenging task that pilot re-
search has shown can be reduced following a
neuromuscular training intervention [36]. Overall, two
parameters of KAM are of interest, the peak KAM and
KAM impulse during tasks of varying difficulty (walking,
one-leg rise, one-leg hop for distance). These tasks were
chosen to determine if medial knee joint load regardless
of task can be reduced following this neuromuscular
program. Due to the time demands on the participants
for laboratory testing, muscle strength and muscle activ-
ity assessment will only be taken from the previously
operated leg. Objective and self-report measures of func-
tion, as well as self-reported measures of symptoms will
provide clinically relevant information and allow com-
parison with other studies. Overall, this study will com-
prehensively quantify the effects of neuromuscular
exercise on biomechanical, functional and clinical mea-
sures associated with knee OA in a population at
increased risk of developing knee OA or progressing
early OA.
A major strength of this study is the pragmatic ap-
proach of treatment delivery by multiple community-based physiotherapists. This delivery approach ensures
that findings will be reproducible and generalisable and
if found effective, will provide sound evidence for a feas-
ible APM rehabilitation option.
Summary
This study uses a randomised controlled design to inves-
tigate the effect of a neuromuscular exercise program
delivered by physiotherapists on medial knee joint load
post-APM. The novel findings will enable evidence-base
recommendations as to the effect of this conservative
option for the reduction of medial knee joint loading in
people considered at high risk to develop knee OA. Fur-
thermore, findings will provide direction for future re-
search into the effect of neuromuscular exercise on knee
joint load.
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